Perampanel
Perampanel is a pharmaceutical drug with 62 clinical trials. Currently 3 active trials ongoing. Historical success rate of 81.6%.
Success Metrics
Based on 40 completed trials
Phase Distribution
Phase Distribution
15
Early Stage
11
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.4%
40 of 51 finished
21.6%
11 ended early
3
trials recruiting
62
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Senicapoc and Perampanel for Newly Diagnosed Glioblastoma
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Population Pharmacokinetics of Antiepileptic in Pediatrics
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
An Extended Access Program (EAP) for Perampanel
Clinical Trials (62)
Senicapoc and Perampanel for Newly Diagnosed Glioblastoma
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Population Pharmacokinetics of Antiepileptic in Pediatrics
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
An Extended Access Program (EAP) for Perampanel
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis
Perampanel in Focal Status Epilepticus
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy
Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 62